Beste Darsh podcasts (2025)

1
Presidential Changes and Impact on Drug Related Misinformation 11:28

8h ago11:28

11:28

Misinformation around vaccines and treatments isn’t new, but with figures like Robert F. Kennedy Jr. in the spotlight, how should regulatory agencies respond? There will be potential changes coming to the FDA and public health regulations with the new administration. Historical transitions, such as the one from the Obama administration to the Trump…

1
23. Louisa Nicola: The Simple Habits That Will Rejuvenate Your Brain 1:30:35

13h ago1:30:35

1:30:35

Your brain is your most powerful asset—so why do so many of us let it decline without a fight? Cognitive decline, brain fog, and even Alzheimer’s don’t just “happen.” They’re the result of decades of small decisions, stress, and overlooked habits. The good news? You have the ability to take control. In this episode of Extend, I sit down with Louisa…

1
Prep for Selling Your Company! 4:10

2d ago4:10

4:10

When preparing to sell your pharmaceutical company, particularly with a Phase 1 product, it’s essential to assess potential buyers and ensure readiness. Darshan’s Insights: When preparing to sell your pharmaceutical company, it’s crucial to evaluate potential buyers and readiness. Key factors include: 1. Compliance Programs: Ensure adherence to OIG…

1
Top Tips for Starting a Clinical Trial Site 6:00

4d ago6:00

6:00

Launching a clinical trial site is an exciting opportunity, but it comes with important legal, regulatory, and operational challenges. Darshan Kulkarni Says: Starting a clinical trial site is an exciting step, but it requires careful planning to address key legal and regulatory considerations. Privacy compliance is a major factor—going beyond HIPAA…

1
[Greatest Hits] Take the Road That Scares the Hell Out of You with Christine Trippi, CEO at The Wise Pineapple 41:05

4d ago41:05

41:05

In this Greatest Hits episode of Getting to Aha!, Darshan Mehta revisits his discussion with Christine Trippi, CEO at The Wise Pineapple, where she travels all over the U.S. to inspire, consult, train, and present keynote speeches based on some of the biggest ideas from her best-selling book: Yes Is the Answer: How Positivity, Passion, and Pineappl…

1
When Drug Reps Visit: Darshan Reacts 4:27

5d ago4:27

4:27

Darshan reacts to a fake interaction between a drug sales representative and a doctor. He shares insights on pharmaceutical marketing tactics, highlighting that while doctors often find sales reps personable, they may not trust them as much as medical science liaisons (MSLs) due to limitations on what reps can legally discuss about drugs. Darshan e…

1
22. How to Break Free from the Sedentary Trap 9:59

6d ago9:59

9:59

Have you ever wondered if hitting the gym is enough to offset hours of sitting at your desk? In this episode of Extend, I take a closer look at the silent yet dangerous effects of sedentary behavior—and why it could be one of the most overlooked threats to your long-term health. From the link between prolonged sitting and chronic diseases like hear…

1
Is Pfizer competing with your pharmacy? 2:29

6d ago2:29

2:29

Pharmaceutical companies, like Pfizer, are venturing into digital healthcare platforms, raising questions about competition with traditional pharmacies. Pfizer recently announced its initiative, "Pfizer for All," a digital platform that offers services such as vaccine scheduling and potential savings on medications, possibly bypassing pharmacy bene…

1
Talking to a Functional Medicine Doctor 23:54

7d ago23:54

23:54

In this episode, guest host Kate Woods interviews Jessica Miller, who shares her journey with functional medicine, highlighting its focus on addressing root causes of illness through personalized, lifestyle-based approaches. They discuss its challenges, benefits, and empowering patients to take charge of their health. Functional medicine focuses on…

1
21. Dr. Jay Shah: The Deadly Effects of Hypertension You’re Not Aware Of 1:30:14

8d ago1:30:14

1:30:14

Do you know the #1 preventable cause of death worldwide? It’s high blood pressure—a condition that half of the population doesn’t even know they have. Mismanaged and misunderstood, this "silent killer" leads to heart attacks, strokes, kidney failure, and dementia. Yet, most people rely on outdated tools like cuffs that deliver inconsistent readings…

1
Four Types of Research related Grant Fraud 4:56

9d ago4:56

4:56

Grant fraud encompasses four critical issues that can have severe repercussions for institutions and individuals: Foreign Influence and Funding: Failing to disclose foreign government support, as seen in Ohio State University's $875,000 settlement (November 2022). Similar allegations against U Ming Qing Xiao in the Southern District of Illinois (Ap…

1
🔒 Leveraging AI and RWD to Reshape Drug Trials! 5:17

11d ago5:17

5:17

Subscriber-only episode In this episode, Darshan explores how artificial intelligence (AI) is transforming clinical trial design, with a focus on using real-world data (RWD). The episode dives into the FDA’s recognition of AI’s potential to enhance clinical trials by using data from electronic health records (EHRs), medical claims, and disease regi…

1
Unlocking Success in Sales: Conversations Over Transactions with Brian Smalley 37:52

11d ago37:52

37:52

In this episode of Getting to Aha!, host Darshan Mehta is joined by Brian Smalley, Executive Vice President of Marketing and Sales at National Steel Car. Brian shares his transformative journey from the U.S. Marine Corps to the railroad industry, revealing how his military discipline shaped his leadership approach. They discuss the evolving nature …

1
DCTs in Oncology: Can They Work? 12:04

13d ago12:04

12:04

The FDA’s 2024 guidance on decentralized clinical trials (DCTs) has the potential to transform clinical research, particularly in oncology. While many still view DCTs as either fully virtual or fully in-person, the guidance promotes a hybrid approach, blending traditional and decentralized elements. This flexibility may help smaller sites participa…

1
Marketing Due Diligence in Stem cell M&A Transactions 6:35

14d ago6:35

6:35

The stem cell industry is growing rapidly but faces heightened regulatory scrutiny, particularly regarding marketing practices. Recent events highlight this issue: Rebecca Tushnet's blog on state "Little FTC Acts" emphasizes their enforcement power against deceptive marketing, and the guilty plea of a stem cell product manufacturer’s CEO for fraud …

1
20. Dr. Rangan Chatterjee: Burnout Is Rewiring Your Brain—Here’s How to Take Back Control 2:35:17

15d ago2:35:17

2:35:17

Are you stuck in a relentless cycle of stress that’s draining your energy and joy? Burnout isn’t just about feeling tired—it’s a chronic state that rewires your body and mind, often without you realizing it. In this episode of Extend, I sit down with Dr. Rangan Chatterjee, a trailblazer in functional medicine and best-selling author, to explore how…

1
Why Are PBMs Blocking Your Meds? - Darshan reacts 4:10

15d ago4:10

4:10

In this episode, Darshan reacts to how at the start of each year, pharmacists often face the challenge of informing patients that their medications are no longer covered due to formulary changes managed by Pharmacy Benefit Managers (PBMs). PBMs, who work for insurance companies, negotiate drug prices and determine which medications are covered, oft…

1
Misleading Ads: Ad laws and Consumer Protection for Marketers 14:10

17d ago14:10

14:10

Rebecca Tushnet discusses the potential explores the implications of misleading advertisements, particularly concerning pregnancy clinics. Even true statements can be disparaging if they mislead consumers. Cases like the California lawsuit questioning the use of "Dr." titles. Tushnet examines when products like milk can be labeled as such and scrut…

1
[Greatest Hits] Data-Driven Content with Becky Lawlor, Chief Research and Content Officer at Redpoint 33:31

18d ago33:31

33:31

In this Greatest Hits episode of Getting to Aha!, Darshan Mehta revisits his discussion with Becky Lawlor, Founder and Chief Research and Content Officer at Redpoint. Together, they explore the power of niche research in content marketing, the critical role of research in crafting high-quality content, the transformative impact of AI, and the value…

1
5 Common Clinical Trial Site Failures 1:07

19d ago1:07

1:07

Darshan discusses the five most common clinical trial site issues: 1. Failure to Follow Investigational Plan: Treating clinical trials like routine medical practice instead of strictly following the protocol can lead to serious issues. 2. Inadequate and Inaccurate Records: The FDA emphasizes that if it’s not documented, it didn’t happen. Inaccurate…

1
19. The Supplement Myths You Need to Stop Believing 11:21

20d ago11:21

11:21

Have you ever felt overwhelmed by the endless options in the supplement aisle? In this episode of Extend, I take a closer look at why so many people struggle to make sense of supplementation—and what you can do to make smarter, science-backed decisions. From the declining nutrient density in modern diets to the role of supplements in addressing def…

1
Faster FDA Recalls 4:06

21d ago4:06

4:06

The FDA’s Center for Devices and Radiological Health (CDRH) has launched a groundbreaking initiative aimed at improving the efficiency and speed of recall communications for medical devices. Here are the five key strategies from the FDA's new medical device recall initiative: Faster Alerts for High-Risk Devices: The FDA aims to reduce the time betw…

1
18. Dr. Dale Bredesen: This Hidden Risk is Damaging Your Brain, Can Alzheimer’s Be Reversed + The New Breakthroughs Everyone Needs to Know 1:19:37

22d ago1:19:37

1:19:37

Have you ever wondered if memory loss or cognitive decline is inevitable as we age? What if I told you it’s not—and that, with the right strategies, you can even reverse early signs of neurodegeneration? In this episode of Extend with Dr. Darshan Shah, I sit down with my friend and esteemed colleague, Dr. Dale Bredesen, a pioneer in brain health an…

1
IRB Challenges and Updates for 2024 15:07

22d ago15:07

15:07

In this episode, Edye Edens and Darshan Kulkarni discuss the evolving landscape of IRB oversight in 2024, including the roles of HRPP, AAHRPP, and OHRP, and the need for greater federal agency involvement. They also cover the impact of new guidance, the Trump administration, and the FDA's relationship with IRBs. We discuss: 1. The FDA’s Finalized G…

1
Is the Polio Vaccine Safe? 5:45

23d ago5:45

5:45

The polio vaccine, credited with eradicating a crippling disease in the U.S., faces renewed scrutiny after attorney Aaron Siri, linked to Robert F. Kennedy Jr., petitioned the FDA to revoke its approval. Kennedy, nominated as Health and Human Services Secretary, has distanced himself from the "anti-vaccine" label but calls for further vaccine studi…

1
FDA blue print to discuss off label topics 8:40

25d ago8:40

8:40

FDA has changed its mind about off label marketing. Today, we're diving into how drug and device companies can effectively engage with payers and providers, exploring recent updates and guidelines. Let’s start with the basics: FDA Regulations and the First Amendment. The FDA’s ability to impose restrictions on speakers and content is limited by the…

1
[Greatest Hits] Unlocking Cultural Insights in Branding with Kalil Vicioso, Principal Consultant at Tiny Hat Consulting 49:26

25d ago49:26

49:26

In this Greatest Hits episode of Getting to Aha!, Darshan Mehta welcomes Kalil Vicioso, Principal Consultant at Tiny Hat Consulting, a firm dedicated to empowering brands through cultural and consumer insights. Kalil also serves as a Board Member for Insights in Color. Together, they explore Kalil's Aha! journey, his dynamic career, and his work on…

1
17. Why Your Diet Isn’t Working (And What Actually Does) 12:21

27d ago12:21

12:21

Are you trapped in the cycle of endless dieting and calorie counting? For years, we've been told that weight loss is as simple as “calories in, calories out,” but if that’s true, why do so many of us still struggle? What if the problem isn’t just the numbers, but how we think about them? In this episode of theExtend podcast, I take a closer look at…

1
🔒 Opportunities AI provides in Clinical Research 3:50

27d ago3:50

3:50

Subscriber-only episode Today, we're discussing the FDA's use of artificial intelligence (AI) to transform clinical trials. AI is emerging as a cornerstone in clinical research, with the FDA recognizing its potential in several key areas. First, predictive modeling allows AI to optimize pharmacokinetic profiles, streamlining dosing regimens and enh…

1
16. JJ Virgin: The Real Reason You’re Not Building Muscle (+ What to Do Instead) 1:44:41

29d ago1:44:41

1:44:41

Ever find yourself putting in the time at the gym, only to feel like you’re barely moving the needle? Or notice that staying in shape seems to get tougher every year? Here’s the thing: muscle health is the backbone of your metabolism, strength, and long-term vitality, but it’s often the missing link in most people’s routines. In this episode, I’m t…

1
Telehealth and Biohacking: A Risky Combination 3:06

29d ago3:06

3:06

The rise of biohacking has transitioned from a niche interest to a mainstream trend, particularly in the context of drugs like Ozempic and ketamine. While biohacking aims to enhance human performance and health, it raises significant questions about the risks and benefits, especially concerning telehealth services. Individuals are increasingly seek…

1
Is the FDA’s Response to AI Falling Behind? 2:05

1M ago2:05

2:05

The FDA’s current approach to AI in healthcare highlights significant gaps in regulatory preparedness. Although the FDA has approved thousands of AI-enabled tools, it still lacks the resources, clear guidelines, and enforcement power necessary to address the rapid advancements and risks of AI effectively. The agency has issued frameworks and adopte…

1
Healthcare Is in Crisis: How do we fix it? 17:54

1M ago17:54

17:54

In this episode, guest host Kate Woods and Darshan Kulkarni delve into current healthcare issues, including the unsettling news of the CEO of United Healthcare being shot. They discuss the broader implications of this event, questioning how it reflects the state of the healthcare system and whether CEOs in troubled companies are becoming targets. T…

1
Unlocking the Power of Social Insights with Maz Nadjm 26:01

1M ago26:01

26:01

In this episode of Getting to Aha!, host Darshan Mehta is joined by Maz Nadjm, a leading figure in the world of social media and generative AI. Maz shares his journey from programming to becoming a global leader in AI marketing at Tata Consultancy Services, detailing his path through roles at Ogilvy, Wipro, and Sky. The conversation explores the ev…

1
Will RFK Break Pharma? 2:46

1M ago2:46

2:46

Robert F. Kennedy Jr. has announced plans for a presidential mandate to restore federal agencies, including the FDA, to the "gold standard" of scientific review. This bold proposal has significant implications for the life sciences industry, affecting drug advertisers, clinical researchers, and M&A attorneys. Key Takeaways by Sector For Drug Advert…

1
15. How to Reverse Metabolic Syndrome 15:55

1M ago15:55

15:55

Are you part of the 88% of people who are metabolically unhealthy—and don’t even know it? Do you know what metabolic health really means? Or why is it the root cause of nearly every chronic disease? In this episode of Extend, I’m diving deep into the critical world of metabolic health—how it works, why it matters, and what you can do today to optim…

1
Fake data in Clinical Trials 1:58

1M ago1:58

1:58

Florida medical clinic owner and staff were charged with falsifying clinical trial data. According to the indictment, from September 2015 to March 2018, the defendants at AMB Research Center in Miami fabricated clinical trial data for profit. They knowingly enrolled subjects who did not meet eligibility criteria, falsified lab data and medical reco…

1
14. Darin Olien: The Deceptive Nature of Ultra-Processed Foods, Toxins in our Products, Top Tips on Nutrition, Daily Stress Busters + More 1:52:56

1M ago1:52:56

1:52:56

What if simple lifestyle changes could transform your health in ways you never imagined? In this episode of Extend with Darshan Shah, MD with my guest, Darin Olien, we dig into the basics—nutrition, exercise, and stress management—that lay the foundation for a healthier life. Darin also explains why cutting out ultra-processed foods in favor of fre…

1
Darshan Fixes Big Pharma Misconceptions 3:00

1M ago3:00

3:00

In this reaction video, Darshan responds to claims about the effectiveness of prescribed medications. While patients often expect their drugs to work, a statement suggesting that only 20% of people benefit from these medications is misleading. Darshan emphasizes that the FDA focuses on ensuring drugs are not harmful and assesses efficacy based on t…

1
How Trump’s Tariffs will Disrupt Clinical Trials and Drug Marketing? 6:50

1M ago6:50

6:50

In today's podcast, we dive into President Trump's proposed tariffs on Canada, Mexico, and China and what these moves could mean for the life sciences industry. Tariffs, essentially taxes on imported goods, are designed to protect domestic industries by making foreign goods more expensive. While the Trump administration believes tariffs will boost …

1
Compassion, Critical Thinking, and Change with Hawah Kasat 41:53

1M ago41:53

41:53

In this episode of Getting to Aha! Host Darshan Mehta engages Hawah Kasat, a global humanitarian and co-founder of One Common Unity, in an inspiring discussion about the transformative power of moments. Hawah shares his journey, shaped by his early travels, passion for peacebuilding, and commitment to fostering connection through education and the …

1
13. Are You Fueling or Failing Your Body? 15:26

1M ago15:26

15:26

Are you overwhelmed by all the conflicting diet advice out there? In this episode of Extend, I simplify it all with a framework that works: the good, the bad, and the ugly of food. We’ll dive deep into how to structure your meals around nutrient-dense choices that nourish your body, help you maintain energy, and support long-term health. I’ll walk …

1
Why China is Targeting Top Scientists! 3:22

1M ago3:22

3:22

The Wall Street Journal recently reported that China is aggressively targeting tech talent with lucrative job offers, offering triple the pay for positions in the chip-making industry, sparking concerns in the West. This trend isn't unique to tech; similar tactics have been used in the life sciences. For instance, a Harvard law professor was charge…

1
12. Kayla Barnes-Lentz: Female-Specific Health Approach, Reducing Toxins from Daily Products, Aligning Routines with Menstrual Cycles, Understanding Your Genetics + More! 1:38:19

1M ago1:38:19

1:38:19

What if you could get the full potential of your health by tailoring it to your unique genetic blueprint? Ever wondered how personalized wellness could transform your approach to health and well-being? In this episode of Extend with Dr. Shah, we dive into this fascinating concept with biohacking expert Kayla Barnes Lentz, a pioneer in personalized …

1
Trump’s Bold Picks Shake Up Life Sciences 4:52

1M ago4:52

4:52

The Trump administration’s new appointees, including Elon Musk, Dr. Marty Makary, Dr. Jay Bhattacharya, and Robert F. Kennedy Jr., promise a significant shift for the life sciences industry. Each brings a disruptive approach to their respective agencies, signaling potential changes in clinical research, drug advertising, and regulatory oversight. K…

1
3 Regulatory Opportunities in Clinical Trials! 5:27

2M ago5:27

5:27

We explore the rapidly evolving role of artificial intelligence (AI) in clinical trial research design. He discusses how AI is reshaping the pharmaceutical landscape and highlights key areas identified by the FDA where AI is expected to make a significant impact. Darshan delves into the transformative power of digital health technologies, which ena…

1
From English Major to EdTech Leader: John Jorgenson’s Transformative Journey 35:09

2M ago35:09

35:09

In this episode of Getting to Aha! Host Darshan Mehta interviews John Jorgenson, CMO of Cambium Learning Group, to explore the interplay of education, marketing, and technology. John reflects on his career transition from English major to EdTech marketing leader, emphasizing the importance of aligning marketing strategies with educators' and studen…

1
11. Can The Damage of Ultra-Processed Foods Be Stopped? 12:38

2M ago12:38

12:38

We’ve all been there—grabbing a quick snack or packaged meal, trusting it to be “not that bad.” But what if I told you these ultra-processed foods are quietly undermining your health? Engineered for taste and convenience, they’re doing far more harm than you realize, contributing to fatigue, metabolic issues, and even chronic disease. If you’re ser…

1
Don't Take Non-Prescription Ozempic or other Weight Loss Drugs 3:15

2M ago3:15

3:15

We explore the emerging trend of patients bypassing traditional healthcare to obtain weight loss medications like Ozempic through unofficial channels and telehealth platforms. This underground movement raises serious ethical and legal concerns, as individuals manipulate systems to access these drugs without proper prescriptions, risking their healt…

1
Clinical Trial Principal Investigator Duties in Clinical Trials 2:32

2M ago2:32

2:32

The FDA has stressed the critical importance of adequate supervision and monitoring in clinical trials to ensure they are conducted properly. A key figure responsible for this oversight is the Principal Investigator (PI), as outlined in 21 CFR 32.6. The PI must ensure the trial follows the protocol and all applicable regulations, and that the right…

Podcasts die het beluisteren waard zijn

Darsh Podcasts

Podcasts die het beluisteren waard zijn

Korte handleiding